8/2017 Notice by the Management Board of Medicalgorithmics S.A. of the Annual General Meeting to be held on 20 June 2017

Notice by the Management Board of Medicalgorithmics S.A. of the Annual General Meeting to be held on 20 June 2017

Current report 8/2017

The Management Board of MEDICALGORITHMICS Spółka Akcyjna with its registered office in Warsaw at Al. Jerozolimskie 81, 02-001 Warsaw, entered in the Register of Entrepreneurs kept by the District Court for the capital city of Warsaw in Warsaw, 12^th Commercial Division of the National Court Register under KRS No 0000372848 (“Company”), acting pursuant to Article 399(1) of the Code of Commercial Companies (“CCC”), hereby convenes an Annual General Meeting of the Company (“General Meeting”) and in accordance with the wording of Article 402² of the CCC, presents the following information:

1. DATE, TIME AND PLACE OF THE GENERAL MEETING AND A DETAILED AGENDA

The Management Board of the Company convenes the General Meeting for 20 June 2017 at 2:00 pm at the registered office of the Company, i.e. in the office premises at Al. Jerozolimskie 81, on the 19^th floor of the Central Tower building in Warsaw, with

the following agenda:

1. Opening of the General Meeting;
2. Election of the Chairperson of the General Meeting;
3. Confirmation that the General Meeting has been properly convened and has the legal capacity to adopt resolutions;
4. Adoption of a resolution approving the agenda of the General Meeting;
5. Presentation of the Company’s financial statements for the financial year 2016, the Directors’ report on the Company’s operations in the financial year 2016, the consolidated financial statements of the Medicalgorithmics Group for the financial year 2016, the Directors’ report on the operations of the Medicalgorithmics Group in the financial year 2016, the Supervisory Board’s recommendations on the approval of the Company’s financial statements for the financial year 2016, the Directors’ report on the Company’s operations in the financial year 2016, the consolidated financial statements of the Medicalgorithmics Group for the financial year 2016, as well as the Directors’ report on the operations of the Medicalgorithmics Group in the financial year 2016, and the Supervisory Board’s report for the financial year 2016;
6. Review the Company’s financial statements for the financial year 2016, the Directors’ report on the Company’s operations in the financial year 2016, and adoption of a resolution on their approval;
7. Review the consolidated financial statements of the Medicalgorithmics Group for the financial year 2016, as well as the Directors’ report on the operations of the Medicalgorithmics Group in the financial year 2016, and adoption of a resolution on their approval;
8. Adoption of resolutions on granting discharge to individual members of the Company’s Management Board in respect of performance of their duties in the financial year ended 31 December 2016;
9. Adoption of resolutions on granting discharge to individual members of the Company’s Supervisory Board in respect of performance of their duties in the financial year ended 31 December 2016;
10. Adoption of a resolution on allocation of the net profit reported in the Company’s financial statements for the financial year 2016;
11. Closing of the General Meeting.